泰安东马各庄村200一次(泰安东马各庄村实行200元一次投资 转化为新标题可为:泰安东马各庄村推出200元一次投资计划)

2024-03-29 06:59:43 | 来源:灯小并的新闻网
小字号

泰安东马各庄村推出200元一次投资计划,为当地居民提供了创业的机会。该计划可投资于多个项目,如养殖业、种植业、农业等领域,旨在促进当地经济的发展,带动村民增收致富。

1. 投资计划的背景

作为一个处于中国山东省泰安市的村庄,东马各庄村拥有得天独厚的自然资源和农业优势。但是,由于一些历史原因,村庄发展缓慢,当地居民特别是年轻人缺乏就业机会,生活压力增大。因此,村委会萌发了推出投资计划的想法,为当地居民提供赚钱的机会。

2. 投资计划的实施

为了确保投资计划的成功,东马各庄村委会积极策划,与专业的投资机构合作,共同推出了200元一次的投资计划。计划不仅倡导“小投入、大回报”,还鼓励村民参与公益事业,为村庄的发展添砖加瓦。

投资计划的实施不仅为当地居民带来创业的机会,还为村庄的发展注入了新的活力。计划所涉及的项目也广泛,如养殖业、果蔬种植、农业生产等领域,自主创业能力强的村民不仅可以实现个人的收入增长,还可以为当地居民提供就业机会,促进村庄的发展。

3. 投资计划的成果

通过投资计划的实施,东马各庄村的发展出现了明显的好转。村庄的经济实力增加了,当地居民的生活质量也得到了提升。而且,投资计划不仅在经济上带来了好处,还为当地居民带来了精神上的鼓舞,让他们看到了村庄发展的希望和未来的美好。

4. 投资计划的启示

东马各庄村推出的投资计划,成功地为当地居民提供了创业机会,推动了村庄的发展。而这也启示我们,在农村创业领域,只要真正关注当地居民的需求,开拓创新,充分利用当地资源,努力为当地居民提供更好的生活条件,就一定能够推动当地经济的快速发展。只有这样,才能够不断增强农村的发展活力,不断壮大农村经济的实力。

总之,东马各庄村的投资计划,成功地为当地居民带来了创业的机会,推进了村庄的发展,为我们在农村创业领域提供了很好的借鉴和经验。


(责编:admin)

分享让更多人看到

Asia Cell & Gene Therapy Innovation Summit 2024
  • Apr. 2nd - 3rd 2024
  • Shanghai, China

CGT Asia 2024 - The 5th Asia Cell & Gene Therapy Innovation Summit 2024
3DCC 2024 - The 2nd 3D Cell Culture and Organoid R&D Summit
CGT Awards - 2024 Asia Pacific Cell and Gene Therapy Innovation Star of the Year Award

0 +

Keynote
Speeches

0 +

Professional
Attendees

0 +

Featured
Booths

0 +

Global Cell&Gene
Therapy Enterprises

0 +

Media
Reports

Key words of the conference

Commercialization and Innovative Drug Access to Hospitals, Clinically Oriented and Innovative Therapies, Stem Cell Therapy, Extracellular Vesicles Therapy, MSC EV, Cell Therapy, Gene Therapy, RNA Therapy, Oncolytic Virus, Rare Disease, Tumor Microenvironment, Non-coding RNAs, Epigenetic, Single-Cell Sequencing, Biomarkers, Universal Cancer only Maker (UCOM), Immune Cell, TCR-T, CAR-NK, 3D Cell Culture, Organoid Model, CRISPR/CAS9 Gene Editing, iPSC, PCR, High-Throughput Screening, Application Plans,Continuous Production Process, GMP, AAV, (Non-) Viral Vectors, LNP etc.

Chips-on-Organoid, Microfluidic Technology, 3D Bio-Printing,Organoid vascularization, Advances in Cutting-Edge Technologies, Standardization and Application Scenarios, Clinical Research Applications, Drug Sensitivity Screening, R&D Applications, Efficacy Study, Cross-Cutting Technologies, Regenerative Medicine, Discussions on Laws and Regulations, etc.

Topics Highlights
The 5th Asia Cell and Gene Therapy Innovation Summit 2024
  • Case Study of Marketed Targeting CD19 CAR-T Cell Therapy Clinical Trials

  • Progress of Clinical Research on Mesenchymal Stem Cell Therapy for End-Stage Liver Disease

  • Highlights of Before and After Marketing Changes for Cell Therapy Drugs

  • Top CDMO Takes Your Cell Culture from Customization to Global Standardization

  • Role and Mechanisms of Cardiac-Derived Exosomes in Oncological Cardio Therapy

  • Bring In or Going Overseas--How to Accelerate the Commercialization of Cell Therapy?

  • Recent Clinical Advances in Gene Therapy for Hereditary Deafness

  • Novel Malignant Tumor Therapeutic Strategy - Lysovirus Enhances The Anti-Tumor

    Effect of DC Vaccines

  • Efficient Dual AAV Carrier Development Optimization and Design

  • Application and Progress of Small Nucleic Acid Drugs in The Field of Chronic Diseases

    such as Cardiovascular Diseases

  • ......

2024 3D Cell Culture Organoid R&D Summit

  • Regenerative Medicine Through The Eyes of An Investor

  • Microfluidic Chip-Assisted Vascularisation of Human Brain Organoids

  • Construction of Novel Human Endometrial Organoids

  • Research on Human Bionic Organoid and Organ-on-a-Chip Based on Neural Innervation

  • Clinical Case Sharing of Heart Transplantation for Heart Failure

  • Quality Control of Organoid Drug Sensitivity Testing Throughout the Entire Process

  • ......


At a Glance

3-2312121626223a.png


3-231120145302209.png

Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show


Part of Speakers

Prof. Xinhua LIN
Prof. Xinhua LIN

President

School of Life Sciences Fudan University /  Greater Bay Area Institute of Precision Medicine

Prof. Zibing JIN
Prof. Zibing JIN

Deputy President of Beijing Tongren Hospital

Beijing Tongren Hospital Capital Medical University, Beijing Institute of Ophthalmology

Prof. Cheng QIAN
Prof. Cheng QIAN

CSO

Precision Biotech

Prof. Wei ZUO
Prof. Wei ZUO

Chairman

Regend Therapeutics

Prof. Hao SHEN
Prof. Hao SHEN

CSO

FOSUNKite

Dr. Maryland Franklin
Dr. Maryland Franklin

VP

Labcorp

Dr. Aron  JAFFE
Dr. Aron JAFFE

SVP

Chroma Medicine

Prof. Jonathan  Yuin-Han LOH
Prof. Jonathan Yuin-Han LOH

Director

A*STAR IMCB

Dr. Noriyasu ISHIKAWA
Dr. Noriyasu ISHIKAWA

CEO

Solallis Bio Inc.

Dr. David DU
Dr. David DU

Co-founder, CEO

Evergreen Therapeutics

Prof. Hongming HU
Prof. Hongming HU

CSO

ImmuXell

Prof. Guoying ZHOU
Prof. Guoying ZHOU

Chairman & CEO

ImmVira

Dr. Joan SHEN
Dr. Joan SHEN

Founder & CEO

NeuShen Tx

prof. Wenbin Qian
prof. Wenbin Qian

Founder

Rongu bio

Dr. Cecilia ZHANG
Dr. Cecilia ZHANG

CSO

Biosyngen

Mrs. Lanlin WU
Mrs. Lanlin WU

CEO

Carcell Biopharma Ltd.

Dr. Baohong ZHANG
Dr. Baohong ZHANG

CEO

Epigenic Therapeutics, Inc.

Dr. Minmin SUN
Dr. Minmin SUN

Chairman & CEO

Immunofoco

Prof. Alex H. Chang
Prof. Alex H. Chang

CEO

YaKe Biotech

Dr. Huashun LI
Dr. Huashun LI

Chairman

Ascle Therapeutics

Mr. Zhenhua Luo
Mr. Zhenhua Luo

PI

The First Affiliated Hospital of Sun Yat-sen University

Prof. Peng LIU
Prof. Peng LIU

Prof

Tsinghua university

Dr. Adam ZHAO
Dr. Adam ZHAO

Founder

Anlongbio

Dr. Binghe TAN
Dr. Binghe TAN

Co-Partner, Vice President of Production and CMC

BRL Medicine Inc.

Prof. Guoqiang HUA
Prof. Guoqiang HUA

Founder of D1 Medical

D1 MEDICAL TECHNOLOGY

Dr. Jun Li
Dr. Jun Li

CEO

Fundamentatx

Prof.  Bing Zhao
Prof. Bing Zhao

Prof

fudan university

Dr. Yuan CAI
Dr. Yuan CAI

CEO/Co-Founder

Starrygene Therapeutics

PI. Liang Li
PI. Liang Li

PI

southern medical university

Dr. Xiaofang Tang
Dr. Xiaofang Tang

Dr

GBA-IPM

Dr. Yi JIN
Dr. Yi JIN

CEO

GeCell Therapeutics

Mr. Zhihui Weng
Mr. Zhihui Weng

vp

sharecaptal

Dr. Libo ZHAO
Dr. Libo ZHAO

CTO

Echo Biotech

Dr. Andrew LIN
Dr. Andrew LIN

CEO

Lingyi Biotech Co., Ltd.

Dr. Yarong LIU
Dr. Yarong LIU

Founder/CEO

Grit Biotechnology

Dr. Wenmin ZHU
Dr. Wenmin ZHU

Marketing Director

T&L Biotechnology

Prof. Donghui ZHANG
Prof. Donghui ZHANG

Prof

Hubei university

Dr. Lang Zhang
Dr. Lang Zhang

Head of CMC-PD mRNA, in vivo Platform

CorrectSequence Therapeutics

Mr. Yun LIU
Mr. Yun LIU

Chairman/President

Huayi Capital/Huayi Research Institute

Dr. Yu ZHANG
Dr. Yu ZHANG

Founder/CEO

VCANBIO Life Science

Dr. ZhengBo SU
Dr. ZhengBo SU

Chairman

TCRCure Biopharma Ltd.

Dr. Junjie PENG
Dr. Junjie PENG

Chief Physician, Colorectal Surgery

Fudan University Shanghai Cancer Center

Dr. Ming YUAN
Dr. Ming YUAN

Chairman

Huayaokangming

Dr. Ying ZHANG
Dr. Ying ZHANG

Co-founder, CTO

Nuwacell

Dr. Xiang LI
Dr. Xiang LI

Chairman&Founder&CEO

XellSmart

Dr. Qiang CHEN
Dr. Qiang CHEN

CTO

DanausGT

Dr. Xueliang YU
Dr. Xueliang YU

VP

Starna Therapeutics

Mr. Gang LU
Mr. Gang LU

vp

shlifestemcell

Mrs. Zhong ZHAO
Mrs. Zhong ZHAO

BU Head & Chief Product Officer

DXY Insight Database

Dr. Wee Kiat TAN
Dr. Wee Kiat TAN

Co-CEO & COO

CytoMed Therapeutics

Dr. Xuedong DAI
Dr. Xuedong DAI

VP

collectively known as SAFE GLP

Mr. Victor YU
Mr. Victor YU

Country Manager of Greater China

Astrea Bioseparations Ltd

Dr. Lifan WEI
Dr. Lifan WEI

Senior Investigator

INADRD, CSPC

Dr. Zhou LI
Dr. Zhou LI

CSO

Juventas Cell Therapy LLC

Mr. Jack ZHANG
Mr. Jack ZHANG

Strategy and Business Development Lead, CGT APAC

Lonza

Dr. Zhao ZHU
Dr. Zhao ZHU

Co-founder/Chairman/CEO

Neuregen Therapeutics

Dr. Ramin BAGHIRZADE
Dr. Ramin BAGHIRZADE

Global Head Commercial – Gene Therapy CDMO Services

Charles River丨Biologics Solutions

Dr. Wenji DONG
Dr. Wenji DONG

Founder & Chairman

Genmedicn

Dr. Forrest CHEN
Dr. Forrest CHEN

CSO

Zhongying Biomedical

Dr. Gaofeng ZHA
Dr. Gaofeng ZHA

CEO

MagicRNA

Mrs. Wendy LIN
Mrs. Wendy LIN

Key Account Manager

EMBALL'ISO

 Mr.Gary Wang
Mr.Gary Wang

General Manager

kanglitai

Dr. Yang YANG
Dr. Yang YANG

CEO

Genevector Biotech

Dr. Jing FAN
Dr. Jing FAN

Founder & CEO

Hopstem

Mr. Zebin LING
Mr. Zebin LING

CEO

MingCeler

Dr. Ling PENG
Dr. Ling PENG

Medical Director

TCRcure

Prof. Hua LIU
Prof. Hua LIU

Founder, Chief Scientific Officer

Xinghua Bio

Dr. Fan MO
Dr. Fan MO

Co-founder & CEO

Neoantigen

Dr. Xinpo JIANG
Dr. Xinpo JIANG

Associate Vice President of R&D

GenScript

Mrs. Gloria Teng
Mrs. Gloria Teng

Executive Partne

GTJA Investment

Prof. Shuhang WANG
Prof. Shuhang WANG

Attending Doctor

CANCER HOSPITAL CHINESE ACADEMY OF MEDICAL SCIENCE

Mr. Alex CHENG
Mr. Alex CHENG

General Manager

Tofflon

Prof. Zhiyong ZHANG
Prof. Zhiyong ZHANG

Awardee of the First Prize of National Science and Technology Progress Award of China (Top scientific awards in China);Expert of National Talent Program of China;Chief Scientist of REGEN-αGEEK

REGEN-αGEEK

Dr. Luke LI
Dr. Luke LI

BD and Commercial VP

Neurophth Therapeutics

Mrs. Emily TAN
Mrs. Emily TAN

Chief Operating Officer

Unixell Biotechnology

Prof. Mi LIU
Prof. Mi LIU

Founder

Es-Bio

Dr. Hexige Saiyin
Dr. Hexige Saiyin

Assistant professor

Fudan University

Prof. Tianqing LI
Prof. Tianqing LI

Prof

Kunming University of Science and Technology

Dr. Zaozao CHEN
Dr. Zaozao CHEN

CTO

Avatarget

Mr. Chilin WU
Mr. Chilin WU

Partner

DeHeng

Prof. Jie LIU
Prof. Jie LIU

Principal scientist

Eacin Bio

Dr. Lei WANG
Dr. Lei WANG

Department Head of the Cell Resources Center of the National Stem Cell Resource Center

Institute of Zoology, Chinese Academy of Sciences/Beijing Institute of Stem Cell and Regenerative Medicine

Dr. Yi ZHOU
Dr. Yi ZHOU

COO

AimingMed

Prof. Hongju MAO
Prof. Hongju MAO

PI

Shanghai Institute of Microsystems and Information Technology, Chinese Academy of Sciences

Prof. Huaying CHEN
Prof. Huaying CHEN

Prof

Harbin Institute of Technology

Mrs. Katie LI
Mrs. Katie LI

Head of Clinical Operation

CorrectSequence Therapeutics

Dr. Yan XU
Dr. Yan XU

VP

Binhui Biopharm



More guests will continue to update them

Ways to Attend

Increase Your Visibility. Improve Your Reputation

Normal Ticket

  • 1 Pass

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs & Documentation


Exhibition Sponsor

  • 3 Passes

  • 6㎡or 9㎡ Booth for show

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Presentation Sponsor

( Slots Limited)

  • 5 Passes

  • 30 min Speech Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Gold Sponsor

(Exclusive)

  • 5 or More Passes

  • 30 min Speech Opportunity

  • 6or 9 Booth for show

  • Chairman Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Secure your ticket today

Early Bird tickets available now

Secure your spot at CGT Asia our special offer, and don’t go alone, enjoy the best group discount.

Register

Sponsors & Partners

Part of Previous Sponsors

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
26

Part of Media Partners

今日头条
搜狐
药智网
医谷网
CPHI制药在线
会会药咖
镁客网
广动医谷
丁香会议
研发客
肽度
大健康派
生物探索
药源网
基因线上
转化医学网
现代健康网
医药健闻
中国制药设备网
细胞知聊
新康界
医诺医学
美通社
动脉网
医疗器械创新网
新浪医药
中国仪器批发网
细胞世界
戊戌数据
大健康网
嘉裕检测
肽研社
测序宝
基因君
猎药人
化学网
爱爱医
来宝网
生物咖啡茶
生物通
医学信息
中国生物器材网
分析测试百科网
全球医学会议网

Related Meetings